The microbial contract biomanufacturing market is growing at a CAGR of 8.7%, claims {Roots Analysis}

The report features inputs from eminent industry stakeholders, according to whom, currently, over 50% operations related to both API and FDF manufacturing of microbial biologics are outsourced to third party service providers. The report includes detailed transcripts of discussions held with the following experts:

Gaurav Kaushik (Chief Executive Officer and Managing Director, Meteoric Biopharmaceuticals)Debbie Pinkston (Vice President, Sales and Business Development, List Biological Laboratories)Andrea Conforto (Sales and Marketing, Bioservices Director, Olon)Max Rossetto (General Manager, Business Development, Luina Bio)Rob van Dijk (Business Development Manager, WACKER Biotech)

The research covers profiles of key players (listed below); each profile features an overview of the company, information related to its microbial manufacturing focused service portfolio, production facilities and capabilities, and an informed future outlook.

AGC BiologicsAldevronBioVectraEirGenixEtinproEurogentecNorthway BiotechpharmaOlogy BioservicesPorton BiopharmaStelis Biopharma

For additional details, please visit

https://www.rootsanalysis.com/reports/microbial-contract-biomanufacturing-market.html or email [email protected]

You may also be interested in the following titles:

Drug Repurposing Service Providers Market, 2020 – 2030Antibody Discovery Services and Platforms Market (3rd Edition), 2020-2030Live Biotherapeutic Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020 - 2030

Contact:

Gaurav Chaudhary

+1 (415) 800 3415

+44 (122) 391 1091

[email protected]